ArticlePloS one2025
Walking versus running and GFR trajectory in healthy young adults.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe effect of physical activity on the primary prevention of chronic kidney disease (CKD) is unclear. We assessed walking and running as exercise behaviors and their associations with individual-level risk for kidney function decline.
methodsWe conducted a historical cohort study in which we followed 20,976 young adults. Participants were interviewed periodically about their lifestyle, and clinical parameters were assessed. The decline in estimated glomerular filtration rate (eGFR) over time was divided into quartiles. Using logistic regressions, we estimated the odds ratio (OR) for being in the slowest declining quartile by consistency of running or walking. We also used Cox proportional hazards models to estimate the associations of physical activity with future eGFR < 90 ml/min/1.73m2. All models were adjusted for age, sex, smoking status, family history of kidney diseases, BMI, blood-pressure, baseline eGFR and serum cholesterol.
resultsDuring 9.5 years of follow-up, the eGFR decreased by 0.97 ml/min/1.73m2 per year. Participants who reported in two consecutive questionnaires on walking as a leisure time activity had an OR of 1.21 (95% confidence interval: 1.03-1.41) to have slow eGFR decline compared to those who were physically inactive. Participants who predominantly reported on running as their physical activity were less likely to be slow eGFR decliners (OR:0.81, 95% CI:0.71-0.93). Similarly, consistent walking was associated with decreased risk for future eGFR < 90 ml/min/1.73m2 in contrast to consistent running which was associated with an increased risk for reduced eGFR. All associations showed dose dependent effects in terms of the number of weekly activity sessions.
conclusionsConsistent walking, as opposed to consistent running, was associated with slower eGFR decline compared to inactive participants. These associations start already within the normal GFR range.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.